Web www.globalrph.com
Home Back *Drug Tables Disclaimer IV Dilutions *Health topics* Professional Resource 
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

DESMOPRESSIN (DDAVP ®)
Usual Diluents
NS
Standard Dilutions   [Amount of drug]  [Infusion volume]  [Infusion rate]
[0 to 35 mcg/ 50 ml] [15 - 30min]
Stability / Miscellaneous
Supplied: 4 mcg/ml-1 ml vial. 

Indications
: Hemophilia (increases factor VIII levels): 0.3 mcg/kg in 50ml normal saline over 15-30 minutes. 

Diabetes insipidus: 2-4 mcg/day IV push or SC. Decrease bleeding following cardiac bypass: 0.3 mcg/kg ivpb.   Provide short term protection for uremic hemorrhagic tendency: 0.3 mcg/kg ivpb q8h x 2 doses (diminishing response). 

Greatly enhanced ADH activity. Less vasopressor activity. Longer DOA. (Synthetic analog of vasopressin-posterior pituitary hormone). 

ADH activity : Pressor activity 
[DDAVP: 2000-4000: 1   Vasopressin: 1:1]
 


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.